Scott Kinlay, MBBS, PhD
Adjunct Associate Professor, Medicine
Biography
Dr. Scott Kinlay is the Chief of Cardiology and Director of Vascular Medicine at the VA Boston Healthcare System, West Roxbury Campus. He is affiliated with Brigham and Women’s Hospital. He is currently licensed to practice medicine in Massachusetts.
Other Positions
- Associate Professor, Medicine, Harvard Medical School
- Chief, Cardiology, VA Boston Healthcare System
- Director, Vascular Medicine, VA Boston Healthcare System
Websites
Education
- University of Sydney, MBBS
- University of Newcastle, PhD
Publications
- Published on 9/25/2023
Kinlay S. Long-Term Patient Outcomes After Femoropopliteal Peripheral Vascular Intervention in Patients With Intermittent Claudication. JACC Cardiovasc Interv. 2023 Sep 25; 16(18):2335. PMID: 37758389.
Read at: PubMed - Published on 9/4/2023
Evans P, Sobieszczyk P, Eisenhauer AC, Ostrowski S, Todoran TM, Kinlay S. Risk of Mortality Related to Recurrent Limb Events After Endovascular Revascularization of the Superficial Femoral Artery for Peripheral Artery Disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) Study. Am J Cardiol. 2023 Oct 15; 205:425-430. PMID: 37666014.
Read at: PubMed - Published on 7/28/2023
Almarzooq ZI, Al-Roub NM, Kinlay S. Antithrombotic treatment following percutaneous coronary intervention in patients with high bleeding risk. Curr Opin Cardiol. 2023 Nov 01; 38(6):515-520. PMID: 37522805.
Read at: PubMed - Published on 5/21/2023
Kinlay S, Sobieszczyk P, Eisenhauer AC, Ostrowski S, Todoran TM. Patient and limb outcomes 10 years after endovascular revascularization of the superficial femoral artery for peripheral artery disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) study. Vasc Med. 2023 Aug; 28(4):290-298. PMID: 37211818.
Read at: PubMed - Published on 1/16/2023
Kinlay S, Young MM, Sherrod R, Gagnon DR. Long-Term Outcomes and Duration of Dual Antiplatelet Therapy After Coronary Intervention With Second-Generation Drug-Eluting Stents: The Veterans Affairs Extended DAPT Study. J Am Heart Assoc. 2023 Jan 17; 12(2):e027055. PMID: 36645075.
Read at: PubMed - Published on 12/9/2022
Yuyun MF, Kinlay S, Singh JP, Joseph J. Are arrhythmias the drivers of sudden cardiac death in heart failure with preserved ejection fraction? A review. ESC Heart Fail. 2023 Jun; 10(3):1555-1569. PMID: 36495033.
Read at: PubMed - Published on 9/27/2022
Kinlay S. Post-PCI Antithrombotic Treatment With High Bleeding Risk. J Am Coll Cardiol. 2022 Sep 27; 80(13):1238-1240. PMID: 36137673.
Read at: PubMed - Published on 1/24/2022
Goodney P, Shah S, Hu YD, Suckow B, Kinlay S, Armstrong DG, Geraghty P, Patterson M, Menard M, Patel MR, Conte MS. A systematic review of patient-reported outcome measures patients with chronic limb-threatening ischemia. J Vasc Surg. 2022 May; 75(5):1762-1775. PMID: 35085747.
Read at: PubMed - Published on 4/26/2021
Kinlay S, Quach L, Cormack J, Morgenstern N, Hou Y, Young M, Sherrod R, Cho K, Faxon DP, Ramadan R, Gaziano M, Gagnon D. Premature Discontinuation of Dual Antiplatelet Therapy After Coronary Stenting in Veterans: Characteristics and Long-Term Outcomes. J Am Heart Assoc. 2021 05 04; 10(9):e018481. PMID: 33899501.
Read at: PubMed - Published on 4/13/2020
Latif F, Uyeda L, Edson R, Bhatt DL, Goldman S, Holmes DR, Rao SV, Shunk K, Aggarwal K, Uretsky B, Bolad I, Ziada K, McFalls E, Irimpen A, Truong HT, Kinlay S, Papademetriou V, Velagaleti RS, Rangan BV, Mavromatis K, Shih MC, Banerjee S, Brilakis ES. Response by Latif et al to Letter Regarding Article, "Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial". Circ Cardiovasc Interv. 2020 04; 13(4):e009174. PMID: 32279564.
Read at: PubMed
View 147 more publications: View full profile at BUMC